Aldosterone responsiveness to angiotensin II (A II) was evaluated in 64 subjects with "normal renin" hypertension. Plasma aldosterone (PA) and plasma renin activity (PRA) levels were determined with the subjects supine and after 2 72 hours in the upright position while they were in metabolic balance on a 10 mEq of sodium/100 mEq of potassium diet. The increment in PA between supine and upright postures divided by the increment in PRA (APA/APRA) was used as an estimate of adrenal sensitivity to A II. Under identical conditions, the APA/APRA ratio in 11 normal controls was >3.8. Although 52 of the hypertensive subjects had normal APA/APRA, 12 had low APA/APRA. Supine PA and PRA were similar in both groups, but the upright PA was lower (41 vs. 69 ng/dl) and the upright PRA higher (11.1 vs. 7 ng/ml per hr) in the group with the subnormal APA/APRA. 64 subjects (0.1,0.3,1.0, and 3.0 ng/kg per min) . PA and A II levels were measured before and 20 and 30 min after each dose was begun. Blood pressure was monitored at 2-min intervals. In 14 hypertensives with normal APA/APRA, PA rose significantly during the 0.3,1.0, and 3.0 ng/kg per min doses. In five subjects with low APA/APRA, PA did not rise significantly at any dose of A II. Plasma A II levels and blood pressure rose comparably in both groups. These data demonstrate that, in the sodium-depleted state, some "normal renin" hypertensive subjects have decreased aldosterone but normal pressor responsiveness to angiotensin II.
SUBJECTS WITH "normal renin" hypertension were originally thought to be a homogenous group with normal renin-angiotensin-aldosterone (RAA) interrelationships. ' "* There is now, however, a growing body of data suggesting that the RAA axis is abnormal even in "normal renin" subjects. 5 " 11 Recently, Kisch et al. 12 reported that normal renin hypertensives on high sodium intakes had greater aldosterone responsiveness to infused angiotensin II than did normotensive controls on similar diets. Since it has been shown that sodium depletion increases adrenal glomerulosa responsiveness to angiotensin II, 13~1S it could be hypothesized that sodium depleting the hypertensive subjects before infusing angiotensin might magnify the adrenal hyperresponsiveness described by Kisch et al. 12 Thus, it could be demonstrated whether increased adrenal responsiveness to angiotensin II was common to all or just a subgroup of normal renin hypertensives.
The present study was performed to characterize the adrenal's response to angiotensin II in sodium-depleted normal renin hypertensive subjects. Two methods of assessing adrenal responsiveness were employed: (1) the adrenal response to endogenous angiotensin stimulation was determined by relating the incremental response of plasma aldosterone to upright posture to the increment in plasma renin activity; (2) exogenous angiotensin II was infused intravenously in graded doses. Rather than finding an enhanced adrenal response, many of the hypertensive subjects demonstrated subnormal adrenal responsiveness to angiotensin II.
Methods
Sixty-four patients with normal renin essential hypertension (47 males, 17 females) were studied at the Clinical Research Center of the Peter Bent Brigham Hospital and their responses compared with 11 normotensive controls (six males, five females) studied under identical conditions. The age range of the normal subjects was 20-39 (mean of 28 years). Responses in some of these normal subjects have been reported previously. 16 The criteria for inclusion of hypertensive subjects in the study were as follows: outpatient supine diastolic blood pressure greater than 90 mm mercury determined on three different occasions and documented evidence of hypertension for at least 6 months before the study. All antihypertensive medications were discontinued at least 2 weeks prior to admission. The subjects were fed an isocaloric diet of 10 mEq of sodium/100 mEq of potassium. Daily 24-hour urine samples were analyzed for sodium, potassium, and creatinine. Subjects with primary aldosteronism, pheochromocytoma, renal vascular disease, and Cushing's syndrome were ex- VOL. 41, No. 2, AUGUST 1977 eluded by rapid sequence intravenous pyelogram, urinalysis, serum creatinine, serum electrolytes, 24-hour urinary vanillylmandelic acid (VMA), metanephrines, 17-OH, and aldosterone levels, and, where clinically indicated, renal arteriogram and bilateral renal vein renin determinations. Thirty-nine per cent of the 64 subjects reported herein did have a renal angiogram which in all cases was normal. Subjects with high and low renin essential hypertension also were excluded. The normal PRA in our laboratory is 2.4-15 ng/ml per hour (upright posture, 10 mEq of sodium diet). 17 The protocol was approved by the Human Subjects Committee of the Peter Bent Brigham Hospital and written informed consent was obtained in all cases.
UPRIGHT POSTURE STUDY
When subjects had achieved metabolic balance, usually on the 5th or 6th day of sodium restriction, after an overnight fast and maintenance of a supine position for at least 12 hours, two supine control samples were drawn at least 30 minutes apart and the subjects were told to walk for 272 hours. Additional blood samples were obtained after 120 and 150 minutes of upright posture. All samples were analyzed for plasma renin activity, aldosterone and cortisol, serum sodium and potassium, and, in a subpopulation of 16 subjects, angiotensin II levels. Eleven normal controls were studied in an identical fashion.
ANGIOTENSIN II INFUSION
On a different day, during the same hospital stay when the subjects were still in balance on a sodium-restricted intake, 19 of the previously studied hypertensive subjects were infused with angiotensin II. Adrenal and vascular responses to angiotensin II were compared to those of six normotensive controls studied under identical conditions. After an overnight fast, with the subjects in the supine position, an intravenous line was placed in each of the subject's arms (one for infusion and one for blood sampling). Control blood samples were obtained and a graded infusion of angiotensin II (Hypertensin, Ciba) was begun with a Harvard infusion pump at rates of 0.1, 0.3, 1.0, and 3.0 ng/kg per min as previously described. 12 Each dose was infused for 30 minutes and blood samples were obtained at 20 and 30 minutes at each level. All samples were analyzed for angiotensin II, aldosterone, cortisol, sodium, and potassium. Blood pressure was monitored using an indirect recording sphygmomanometer (Arteriosonde, Hoffmann-La Roche) at 2-minute intervals for a 30-minute control period and throughout the angiotensin infusion.
LABORATORY PROCEDURES
All blood samples were immediately centrifuged and the plasma separated and frozen until time for assay. Samples for PRA and A II levels were drawn with ethylenediaminetetraacetic acid (EDTA) as the anticoagulant; heparin was used as the anticoagulant in the samples for cortisol and aldosterone. Serum and urine sodium and potassium levels were measured by flame photometry with lithium as an internal standard. Plasma aldosterone, renin activity, and angiotensin II values were measured by ra-dioimmunoassay techniques as previously described. 18 ' 19 The values for renin activity and angiotensin II were reported in reference to the World Health Organization Standards 71-328 and 70-302, respectively. Therefore, the absolute values may differ somewhat from those reported previously from this laboratory. The results are expressed as mean ± standard error of the mean. Threshold dose during angiotensin infusion is defined as the lowest dose of angiotensin II required to produce a response significantly different from control using two way analysis of variance and P values were obtained in Dunnett's tables. 20 For other statistical analyses for parametric data Student's /-test 21 and for nonparametric data, Fisher Exact Test (FET) were used. 22 Differences are considered significant for P < 0.05 unless otherwise indicated.
Results

UPRIGHT POSTURE STUDY
Release of endogenous renin and generation of angiotensin II were increased by upright posture. The increment in plasma renin activity between supine and upright positions (APRA) was used as an estimate of the degree of acute stimulation of the adrenal gland by angiotensin II. The plasma aldosterone increment (APA) (supine -» upright) was used as a measure of the adrenal response. Thus, the ratio APA/APRA reflects the response of plasma aldosterone relative to changes in plasma renin. The individual ratios for the 64 hypertensives and 11 normotensive controls are shown in Figure 1 . All of the normal subjects had APA/APRA ratios greater than 3.8. In contrast, 12 of the 64 subjects with normal renin essential hypertension (20%) had ratios lower than those of any of the normotensive controls. There were no significant differences in a number of metabolic or biochemical parameters between the normal or low APA/APRA hypertensive subjects (Table 1) . Specifically, there was no diff- erence between the two groups in age, urinary electrolyte excretion either on the day of admission or on the day of study, level of blood pressure, supine plasma aldosterone, cortisol, potassium, or renin activity. However, as would be anticipated because of the method used to separate the groups, the upright plasma aldosterone level was less, while the upright plasma renin activity was greater in the subgroup with the low ratio (Fig. 2 ). For comparison, in the normotensive subjects, the mean supine and upright plasma renin activities were 2.7 ± 0.3 and 9.2 ± 0.8 ng/ ml/per hour and supine and upright plasma aldosterones were 24 ± 5 and 78 ± 14 ng/dl. Since one explanation for the low APA/APRA response could be a decrease in the generation of angiotensin II per unit of renin activity, angiotensin II levels were measured in 16 of 64 hypertensive subjects (nine with normal and seven with low APA/APRA) and all of the normal subjects. The regression relationship between angiotensin II and renin activity was not significantly different between the normal controls (y = 8.1x + 1.7) and the low APA/ APR A hypertensive subjects (y = 7.1x + 15). In both subgroups of hypertensive subjects and in the normotensive controls, the plasma renin activity and angiotensin II values correlated significantly (P < 0.001).
ANGIOTENSIN II INFUSION
To assess more directly the adrenal responsiveness to angiotensin II and to compare adrenal and vascular responses, angiotensin II was administered intravenously to 19 (30%) of the 64 hypertensive subjects and to six normotensive controls. Fourteen hypertensive subjects had normal and five had low APA/APRA ratios. There were no significant biochemical or metabolic differences be-tween the two subgroups ( Table 2 ). Figure 3 shows the mean increment in blood pressure, angiotensin II, and aldosterone levels in response to graded infusions of angiotensin II in the two subgroups of hypertensive subjects compared to the normotensive controls. There were no significant differences in the plasma aldosterone or angiotensin II levels obtained at 20 and 30 minutes after the initiation of a particular dose of angiotensin IF; therefore, the 20-and 30-minute values have been pooled.
Angiotensin II levels rose similarly in all three groups. The only difference was at the highest angiotensin II infusion rate for which the increment in angiotensin II in the low APA/APRA hypertensive group was significantly greater (P < 0.005; FET) than in either the normal APA/ APRA group or the normotensive controls. The latter two were not significantly different from each other.
The threshold dose for blood pressure response was 0.3 ng/kg per min in the normal APA/APRA hypertensives and 1.0 ng/kg per min in the low APA/APRA hypertensives and normotensive controls. However, the blood pressure increments at each dose of angiotensin II were not significantly different in the three groups.
A significant increment (P < 0.01) in plasma aldosterone occurred at an infusion rate of 0. hand, in the hypertensive subjects with low APA/APRA, aldosterone level did not significantly increase even at the highest infusion rate. Furthermore, the aldosterone increment at the highest infusion rate in the low ratio subgroup (9.4 ± 3 . 6 ng/dl) was significantly less than in either the normally responsive hypertensive subgroups (25.7 ± 3 . 9 ng/dl; P < 0.04, FET) or in the normotensive controls (24.9 ± 7.1 ng/dl; P < 0.01, FET).
There were no significant differences between the three groups in the plasma cortisol or serum potassium levels during the angiotensin infusion.
Discussion
The present study demonstrates that some subjects with normal renin essential hypertension do not have a normal relationship between the various components of the RAA axis when studied in the sodium-depleted state. However, in contrast to the enhanced adrenal responsiveness found by Kisch et al. 12 in sodium-loaded hypertensives, in 12 of the 64 hypertensives in this study (20%) aldosterone responsiveness was diminished as determined by the ratio of the increment in plasma aldosterone to renin activity in the upright position. The altered adrenal responsiveness in these subjects was directly confirmed by infusing angiotensin II, with the low APA/APRA group responding subnormally both in terms of threshold dose and absolute aldosterone increments. It is important to note that while adrenal responses to angiotensin II were significantly different in the two hypertensive subgroups, blood pressure responses were similar.
Although the state of sodium and potassium balance can influence adrenal responsiveness to angiotensin II, 1^10 no differences in electrolyte balance were found between the hypertensive groups. In addition, because cortisol levels were similar, it is unlikely that the aldosterone levels reflect differences in adrenocorticotropin (ACTH) secretion in the two groups. Another explanation for the difference in aldosterone levels could be an increase in the metabolic clearance rate of aldosterone in the low APA/ APRA group. This is unlikely because only decreases in aldosterone metabolic clearance rates have been reported in essential hypertensives. 23 However, because aldoster-one metabolic clearance in our subjects was not assessed, such a possibility cannot be definitely excluded.
It has been reported that subjects with high circulating angiotensin II levels are less sensitive to both the pressor and aldosterone-stimulating effects of infused angiotensin II. Kaplan 24 found that higher doses of angiotensin II were needed to achieve a rise in blood pressure in subjects with malignant hypertension or cirrhosis and ascites. Ames et al. 25 reported diminished blood pressure and aldosterone responses to angiotensin II in subjects with cirrhosis. These findings suggest that high angiotensin II levels per se may cause relative unresponsiveness to infused angiotensin II. It is unlikely that this phenomenon accounts for the differences found in the hypertensive population in this report for two reasons. First, the angiotensin II levels were within the normal range and identical in both hypertensive subgroups at the start of the angiotensin II infusion (35 pg/ml). Second, in the previous reports, high circulating angiotensin II levels were associated with both pressor and aldosterone hyporesponsiveness to infused angiotensin II. In the present study, the hypertensive subjects with subnormal adrenal responsiveness had normal pressor responsiveness; this suggests a more specific defect in the interaction of angiotensin II with the glomerulosa cell.
It is possible that sodium depletion uncovers a subgroup of normal renin hypertensive subjects with a specific defect in angiotensin-aldosterone interaction. This is unlikely because the distribution of APA/APRA ratios in Figure 1 suggests that there are no distinct subgroups among the hypertensive subjects but rather this group constitutes a single population with a wider range of adrenal responsiveness than in the normotensive subjects. A more likely hypothesis to explain the subjects with subnormal adrenal responsiveness is that dietary sodium content does not alter adrenal sensitivity to angiotensin II as consistently in hypertensive as in normotensive subjects. Thus, the hypertensives' adrenal responsiveness would increase less in the sodium-depleted state and reveal those individuals with low APA/APRA ratios (subnormal adrenal responsiveness). Conversely, sodium loading would suppress adrenal responsiveness less in the hypertensive than the normotensive subjects and reveal the adrenal hyperresponse to angiotensin II reported by Kisch 12 in his hypertensive patients. If this is the case, the present study and Kisch's findings, although seemingly contradictory, could be demonstrating the same phenomenon.
In conclusion, it could be speculated that hypertensive subjects with subnormal adrenal responsiveness, in order to close their renin-angiotensin-aldosterone volume feedback loop, generate more angiotensin II even though the plasma levels are still within the normal range. Since blood pressure response to angiotensin II is normal, the net effect could be an elevated blood pressure. In support of this hypothesis is a preliminary communication which reports that some but not all patients with normal renin essential hypertension show a reduction in blood pressure when given an angiotensin I converting enzyme inhibitor 2 "; this suggests that these that these individuals have an angiotensin-mediated component to their hypertension.
